Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Linoleic acid metabolic pathway
- Molecular classification
- Other (metabolic pathway), Contains Enzymes (such as Δ6-desaturase, cyclooxygenases, lipoxygenases, cytochrome P450s), Contains Metabolites (e.g., gamma-linolenic acid, arachidonic acid)
01
Overview
The linoleic acid pathway encompasses the metabolic conversion of linoleic acid – an essential omega-6 fatty acid – into longer-chain polyunsaturated fats and bioactive lipid mediators, such as gamma-linolenic acid, dihomo-gamma-linolenic acid, and arachidonic acid. Enzymes including desaturases, elongases, cyclooxygenases, lipoxygenases, and cytochrome P450s drive these reactions. The generated metabolites are crucial for the synthesis of signaling molecules (particularly eicosanoids) which regulate inflammation, immune responses, cell growth, and cardiovascular function. While essential in moderate amounts for health (notably skin, neuronal, and immune function), excess intake and oxidative modification of linoleic acid and its derivatives have been associated with various chronic diseases including heart disease, cancer, chronic inflammation, and neurodegenerative disorders. Epigenetic modifications in genes of the pathway may influence psychological resilience and the severity of disorders like PTSD.
- Other names
- Linoleic acid pathwayLinoleic acid metabolismOmega-6 PUFA pathwayLA pathway
02
Mechanism of action
Modulation of enzymatic steps (e.g., inhibition of cyclooxygenase or lipoxygenase enzymes); Regulation of eicosanoid synthesis (prostaglandins, leukotrienes, thromboxanes); Modification of cell membrane lipid composition
03
Biological functions
Lipid synthesis and remodelingMembrane composition and fluiditySynthesis of eicosanoids and oxylipinsRegulation of inflammationSignal transductionAntioxidant responseRegulation of autophagy (cellular recycling)
04
Disease associations
InflammationCardiovascular diseaseNeurodegenerative diseaseCancerMetabolic disorders (diabetes, obesity)Psychiatric disorders (e.g., PTSD, via epigenetic changes)
05
Safety considerations
Excessive intake or accumulation of linoleic acid may promote chronic inflammation and oxidative stress through formation of potentially toxic oxidized metabolitesDietary imbalances (high omega-6/low omega-3) can affect eicosanoid profile and disease risk
06
Interacting drugs
Drugs are not known to directly target the pathway as a whole. Some drugs may modulate downstream metabolites (such as COX inhibitors like aspirin targeting arachidonic acid pathways) or influence dietary intake (supplements).
07
Biomarkers
Levels of linoleic acid, arachidonic acid, and their metabolites in plasma or tissuesOxidized linoleic acid metabolites (OXLAMs, OXAAMs)Gene methylation status in pathway enzymes (e.g., relevant in PTSD)
Beyond the preview
Go deeper on Linoleic acid metabolic pathway.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Linoleic acid metabolic pathway.